Antengene Corporation

• NCT05698147

  Collaborator, Phase 1/2, Recruiting, 30 people, 26 Jan 2023

• NCT05577364

  Collaborator, Phase 1/2, Status unknown, 54 people, 13 Oct 2022

• NCT05422066

  Collaborator, Phase 2, Status unknown, 50 people, 16 Jun 2022

• NCT05422027

  Collaborator, Phase 1/2, Status unknown, 42 people, 16 Jun 2022

• NCT04939142

  Phase 3, Completed, 154 people, 25 Jun 2021

• NCT04425070

  Phase 1/2, Terminated, 56 people, 11 Jun 2020

• Hansoh Pharmaceutical

  Collaboration, 11 Aug 2023

Sources: www1.hkexnews.hk